申请人:Blake James F.
公开号:US20140005213A1
公开(公告)日:2014-01-02
Compounds of Formula I: in which R
1
, R
2
, R
3
, R
4
and R
10
have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
式I的化合物:其中R1、R2、R3、R4和R10具有规范中给出的含义,是可用于治疗由PIM-1和/或PIM-2和/或PIM-3激酶介导的疾病的受体酪氨酸激酶抑制剂。